What they were paid
LIGAND PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $67,039 | $128,142 | $262,888 | $0 | $458,069 |
| FY2024 | $67,065 | $100,235 | $192,613 | — | $359,913 |
| FY2022 | $60,051 | $154,840 | $275,675 | — | $490,566 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LIGAND PHARMACEUTICALS INC DEF 14A filed April 21, 2026, accession 0000886163-26-000021, and prior-year filings. Open the filing on EDGAR.
How this page was built: the LIGAND PHARMACEUTICALS INC filed document, accession 0000886163-26-000021. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.
Get the LIGAND PHARMACEUTICALS Board Governance Report
$458,069 Jason Haas, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025LIGAND PHARMACEUTICALS pays directors a $42,000 cash retainer and $375,000 in RSUs and Options.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Human Capital (Chair) · Strategic Transaction
The rest of the LIGAND PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Jason M. Aryeh | Independent Director | $450,569 |
| John L. LaMattina | Independent Director | $440,569 |
| John W. Kozarich | Independent Director | $473,069 |
| Martine Zimmermann | Independent Director | $444,185 |
| Nancy R. Gray | Independent Director | $448,069 |
| Stephen L. Sabba | Independent Director | $453,069 |
| Todd C. Davis | Director | — |
The full LIGAND PHARMACEUTICALS compensation record
free company briefThis page is one director within LIGAND PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the LIGAND PHARMACEUTICALS proxy · each links to its own free briefOrder LGND
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.